Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update: a nasal spray developed by Meda Pharmaceuticals for seasonal allergic rhinitis has completed the study with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Meda nasal spray

Snippet

Sponsor: Meda Pharmaceuticals | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2010-01-28